{"id":"reversion","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT03619044","NCT03933761","NCT01210755","NCT03895866","NCT02769325","NCT01839968","NCT06195566","NCT04970862","NCT03430349","NCT00130325","NCT00800761","NCT02891278","NCT01742871","NCT01961804","NCT03128151","NCT04879368","NCT01678937","NCT07088822","NCT04851145","NCT06550622","NCT01596985","NCT04544787","NCT03839654","NCT04442620","NCT04920682","NCT06742970","NCT05458973"],"aliases":["KANOKAD"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Reversion","companyId":"university-hospital-angers","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"University Hospital, Angers","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Reversion","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03619044","phase":"NA","title":"The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzuma","status":"TERMINATED","sponsor":"Institut Claudius Regaud","isPivotal":false,"enrollment":4,"indication":"HER2-positive Breast Cancer","completionDate":"2021-07-09"},{"nctId":"NCT03933761","phase":"Phase 2","title":"A Phase II, Signal-Seeking Trial of the Clinical Benefit Rate Associated With Pamiparib in Subjects With Germline or Somatic BRCA1/2 High Grade Serous Ovarian Cancer or Carcinosarcoma Who Have Progres","status":"WITHDRAWN","sponsor":"Australia New Zealand Gynaecological Oncology Group","isPivotal":false,"enrollment":0,"indication":"Ovarian Cancer, Carcinosarcoma","completionDate":"2021-08-02"},{"nctId":"NCT01210755","phase":"Phase 4","title":"Reversion of the Anticoagulant Effect of the New Antithrombotic Agents Anti-Xa and Anti IIa by Specific and Non-specific Haemostatic Drugs,: an Ex-Vivo Study in Healthy Volunteers","status":"COMPLETED","sponsor":"University Hospital, Grenoble","isPivotal":false,"enrollment":10,"indication":"Venous Thromboembolism","completionDate":"2011-06"},{"nctId":"NCT03895866","phase":"N/A","title":"Clinical Study on the Relationship Between Persistent Cervical HPV Infection With Clearance and Vaginal Microbial Community","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","isPivotal":false,"enrollment":240,"indication":"HPV-Related Squamous Cell Carcinoma","completionDate":"2020-02-11"},{"nctId":"NCT02769325","phase":"Phase 4","title":"Atropine in Laparoscopic Gynaecological Surgery (The ALGOS Trial) A Randomised, Double Blind, Controlled Trial","status":"UNKNOWN","sponsor":"Clinica Santa Maria","isPivotal":false,"enrollment":150,"indication":"Laparoscopic Surgery, Gynecology","completionDate":"2017-08"},{"nctId":"NCT01839968","phase":"N/A","title":"","status":"COMPLETED","sponsor":"University Hospital, Geneva","isPivotal":false,"enrollment":32,"indication":"Acquired Platelet Disorder","completionDate":"2014-01"},{"nctId":"NCT06195566","phase":"N/A","title":"Physics Informed Machine Learning-based Prediction and Reversion of Impaired Fasting Glucose Management","status":"UNKNOWN","sponsor":"Jelizaveta Sokolovska","isPivotal":false,"enrollment":75,"indication":"Prediabetic State, Body Weight","completionDate":"2025-03-31"},{"nctId":"NCT04970862","phase":"N/A","title":"Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration","status":"UNKNOWN","sponsor":"Peking University Third Hospital","isPivotal":false,"enrollment":120,"indication":"Adjacent Segment Disease, Adjacent Segment Degeneration","completionDate":"2023-12-30"},{"nctId":"NCT03430349","phase":"Phase 1","title":"A Phase 1, Blinded, Single Center Study to Evaluate the Safety and Immunogenicity of Two Novel Live Attenuated Serotype 2 Oral Poliovirus Vaccines, Derived From a Modified Sabin 2 Infectious cDNA Clon","status":"COMPLETED","sponsor":"Pierre Van Damme","isPivotal":false,"enrollment":30,"indication":"Poliomyelitis","completionDate":"2017-10-27"},{"nctId":"NCT00130325","phase":"NA","title":"A Double Blind Placebo-controlled Randomized Trial of Isoniazid for the Reversion of a Positive IFNg ELISPOT in TB Case Contacts","status":"COMPLETED","sponsor":"Medical Research Council Unit, The Gambia","isPivotal":false,"enrollment":214,"indication":"Tuberculosis","completionDate":"2009-06"},{"nctId":"NCT00800761","phase":"Phase 4","title":"Increased Survival and Reversion of Iron-Induced Cardiac Disease in Patients With Thalassemia Major Receiving Intensive Combined Chelation Therapy","status":"COMPLETED","sponsor":"Ospedale Microcitemico","isPivotal":false,"enrollment":0,"indication":"Iron Overload, Cardiomyopathy","completionDate":"2006-06"},{"nctId":"NCT02891278","phase":"Phase 1","title":"The Clinical Application of Tumor Reversion: A Phase I Study of Sertraline (Zoloft) in Combination With Timed-sequential Cytosine Arabinoside (Ara-C) in Adults With Relapsed and Refractory Acute Myelo","status":"COMPLETED","sponsor":"Columbia University","isPivotal":false,"enrollment":6,"indication":"Acute Myeloid Leukemia","completionDate":"2020-11-17"},{"nctId":"NCT01742871","phase":"N/A","title":"Nutritional Status of Patients Victims of Haemorragic Accidents With Antivitamins K","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","isPivotal":false,"enrollment":300,"indication":"Hemorrhagic Accident, Iatrogeny","completionDate":"2014-01"},{"nctId":"NCT01961804","phase":"Phase 3","title":"Phase 3 Study Comparing Preventive Reversal of Vitamine K Antagonist Versus Reversion Only in Case of Intracranial Bleeding in Patients Receiving Vitamine K Antagonist Treatment","status":"TERMINATED","sponsor":"University Hospital, Angers","isPivotal":true,"enrollment":202,"indication":"Coagulation; Intravascular, Craniocerebral Trauma","completionDate":"2020-09-03"},{"nctId":"NCT03128151","phase":"N/A","title":"PORCzero: PostOperative Residual Curarization","status":"COMPLETED","sponsor":"Oscar Diaz-Cambronero","isPivotal":false,"enrollment":2314,"indication":"Neuromuscular Blockade","completionDate":"2018-12-31"},{"nctId":"NCT04879368","phase":"Phase 3","title":"A Randomised Phase III Open Label Study of Regorafenib + Nivolumab vs Standard Chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","isPivotal":true,"enrollment":450,"indication":"Gastro-Oesophageal Cancer","completionDate":"2026-06-01"},{"nctId":"NCT01678937","phase":"N/A","title":"Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents","status":"COMPLETED","sponsor":"Northwestern University","isPivotal":false,"enrollment":31,"indication":"Liver Transplant Rejection, Immunosuppression","completionDate":"2008-09"},{"nctId":"NCT07088822","phase":"Phase 1","title":"A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Medigen, Inc.","isPivotal":false,"enrollment":39,"indication":"Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection","completionDate":"2026-12-31"},{"nctId":"NCT04851145","phase":"NA","title":"Diagnostic Value of Mass Spectrometry-based Proteomics in Microvascular Inflammation in Kidney Transplantation, the TranSpec Study.","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","isPivotal":false,"enrollment":141,"indication":"Kidney Transplantation, Graft Rejection","completionDate":"2024-05-05"},{"nctId":"NCT06550622","phase":"N/A","title":"Improved Sensitivity Detection of Serum HBsAg in Chronic Hepatitis B Patients Achieving Functional Cure and Its Association With HBsAg Reversion","status":"RECRUITING","sponsor":"Huashan Hospital","isPivotal":false,"enrollment":300,"indication":"Hepatitis B, Chronic","completionDate":"2027-08-10"},{"nctId":"NCT01596985","phase":"Phase 2","title":"Prospective, Monocentric Study Comparing Cystectomy to PlasmaJet Ablation in the Surgical Management of Ovarian Endometriomas","status":"UNKNOWN","sponsor":"Plasma Surgical Inc","isPivotal":false,"enrollment":50,"indication":"Ovarian Endometrioma","completionDate":"2013-05"},{"nctId":"NCT04544787","phase":"Phase 2","title":"A Phase 2, Partial Blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Immunogenicity of Two Novel Live Attenuated Serotype 2 Oral Poliovirus Vaccines Candidates, in He","status":"COMPLETED","sponsor":"Pierre Van Damme","isPivotal":false,"enrollment":250,"indication":"Poliomyelitis","completionDate":"2019-05-08"},{"nctId":"NCT03839654","phase":"NA","title":"The Role and Mechanisms of Loop Gain and Associated Parameters in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement","status":"UNKNOWN","sponsor":"Nanjing Medical University","isPivotal":false,"enrollment":40,"indication":"Obstructive Sleep Apnea of Adult, Heart Valve Diseases","completionDate":"2023-12-31"},{"nctId":"NCT04442620","phase":"NA","title":"Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity","status":"UNKNOWN","sponsor":"University of the Balearic Islands","isPivotal":false,"enrollment":150,"indication":"Non Alcoholic Fatty Liver Disease","completionDate":"2021-12-01"},{"nctId":"NCT04920682","phase":"Phase 4","title":"Reversal of Moderate (With the Use of Neostigmine 60 mcg/kg) or Superficial (With the Use of Neostigmine 30 mcg/kg) Neuromuscular Blockade Induced by Cisatracurium. A Prospective, Randomized, Controll","status":"COMPLETED","sponsor":"Pontificia Universidade Catolica de Sao Paulo","isPivotal":false,"enrollment":60,"indication":"Neostigmine, Neuromuscular Blocking Agents","completionDate":"2021-08-21"},{"nctId":"NCT06742970","phase":"NA","title":"Impact of a Telematic Intervention Based on Exercise, Nutrition and Education on Frailty Reversion and Prognosis Among Older Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Interve","status":"NOT_YET_RECRUITING","sponsor":"Spanish Society of Cardiology","isPivotal":false,"enrollment":206,"indication":"Aortic Stenosis","completionDate":"2025-12"},{"nctId":"NCT05458973","phase":"N/A","title":"Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.","status":"UNKNOWN","sponsor":"Yonsei University","isPivotal":false,"enrollment":100,"indication":"Ovarian Cancer","completionDate":"2024-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}